Roopal Thakkar

Companies

• AbbVieSVP, Global Therapeutics & CMO Dec 22, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AbbVie ABBV55,374 shares²$15.7M at $283.40Mar 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 27, 2026Shares withheld for tax 8,037 shares at $232.08 of AbbVie²
• Feb 18, 2026Granted 6,638 shares of AbbVie³
• Feb 18, 2026Granted 3,346 shares of AbbVie³
• Feb 18, 2026Granted 2,138 shares of AbbVie³
• Feb 18, 2026Granted 6,015 shares of AbbVie³
• Feb 28, 2025Shares withheld for tax 4,678 shares at $205.02 of AbbVie⁴
• Feb 13, 2025Granted 3,348 shares of AbbVie⁵
• Feb 13, 2025Granted 2,138 shares of AbbVie⁵
• Feb 13, 2025Granted 1,474 shares of AbbVie⁵
• Feb 13, 2025Granted 3,595 shares of AbbVie⁵
• Feb 28, 2024Shares withheld for tax 4,914 shares at $178.99 of AbbVie⁶
• Feb 15, 2024Granted 5,792 shares of AbbVie⁷
• Feb 15, 2024Granted 2,140 shares of AbbVie⁸
• Feb 15, 2024Granted 1,844 shares of AbbVie⁷
• Feb 15, 2024Granted 1,476 shares of AbbVie⁸
• Feb 15, 2024Granted 2,138 shares of AbbVie⁷
• Feb 15, 2024Granted 1,572 shares of AbbVie⁸
• Feb 15, 2024Granted 8,022 shares of AbbVie⁷
• Feb 15, 2024Granted 5,900 shares of AbbVie⁸